The present invention relates to novel pyrimidine derivatives such as compounds of the formula (I) and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.
本发明涉及新型
嘧啶衍
生物,例如式(I)的化合物以及在治疗疾病,特别是由
大麻素2受体活性介导的疼痛方面使用这些化合物或其制药组合物。